CORVO', RENZO GIACINTO
 Distribuzione geografica
Continente #
EU - Europa 29.581
Totale 29.581
Nazione #
IT - Italia 29.581
Totale 29.581
Città #
Genova 21.738
Rapallo 3.450
Genoa 2.596
Vado Ligure 1.747
Bordighera 50
Totale 29.581
Nome #
Helical Tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant 151
Image guided hypofractionated radiotherapy by helical tomotherapy for prostate carcinoma: toxicity and impact on Nadir PSA. 147
2.Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 138
Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck : technical methodology and preliminary results. 137
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 134
Advances in the implementation of helical tomotherapy-based total marrow irradiation with a novel field junction technique. 133
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 131
Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT). 131
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. 130
Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control 129
Preoperative chemotherapy and radiotherapy in the management of epidermoid carcinoma of the anal canal. 127
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes 127
Sequential vs alternate chemo-radiotherapy in advanced head and neck tumors. Report on a randomized study. 126
The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy. 125
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects. 125
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation. 125
Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse. 125
Long-term survival in a patient with head and neck paraganglioma treated with tailored modalities for 20 years: A case report 123
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019 123
Cetuximab and Radiotherapy versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer : A Randomized Phase II trial 121
Feasibility of helical tomotherapy for radical dose retreatment in pelvic area: a report of 4 cases. 120
Rete HTA- Regione Liguria - Criteri per l'appropriatezza allocativa di alcune apparecchiature - Volume 1 Acceleratori Lineari -LINAC 120
Biological and clinical implications for multimodality treatment in patients affected by squamous cell carcinoma of the head and neck. 120
Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer. 119
Comparison of local recurrence among early breast cancer patients treated with electron intraoperative radiotherapy vs hypofractionated photon radiotherapy an observational study 118
Brachiterapia guidata dalle Immagini (MRI) nel carcinoma della cervice localmente avanzato: esperienza mono-istituzionale con 5 anni di follow-up 118
On the delineation of the gross tumor volume and clinical target volume for head and neck squamous cell carcinomas. 117
Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas. 116
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study. 116
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 115
Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report 115
In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. 114
Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study. 114
Endothelial cells increase the radiosensitivity of oropharyngeal squamous carcinoma cells in collagen gel 114
Total body irradiation before allogeneic and autologous bone marrow transplantation: a ten year Genoa experience. 113
Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients. 113
Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck. 113
Kinetic cell analysis by in vivo bromodeoxyuridine in squamous head and neck cancers: a tool for the radiotherapist. 113
Reduction Mammaplasty and Intra-Operative Radiotherapy (IORT) in Conservative Surgery 113
Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. 112
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019. 112
Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. 112
New experience with breast volumetric modulation arc therapy (VMAT) realized with Trilogy Linac:comparison with Tomotherapy, Pros and Cons 112
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 112
Radiation-induced emesis: a prospective observational multicenter italian trial 109
Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer 109
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 109
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study 108
Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. 108
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 108
Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. 107
Bone marrow transplantation (BMT) for acute nonlymphoid leukemia (ANLL) in first remission. 107
Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. 107
Abdomino-pelvic radiotherapy (moving strip technique) after polichemotherapy with cisplatinum (CDDP) and second look laparatomy. Pilot study in advanced ovarian cancer. 107
Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey 107
Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer 107
Accelerated partial breast irradiation via the mammosite catheter: preliminary reports of a single-institution experience. 106
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. 106
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation. 106
Tossicità acuta e tardiva correlata a radioterapia ipofrazionata dopo chirurgia conservativa associata o meno a chemioterapia adiuvante per neoplasia mammaria in stadio iniziale: boost IORT versus Concomitant boost 105
48: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. 105
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. 104
Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity. 104
Excellent survival regardless of disease stage in patients with advanced nasopharyngeal cancer 104
Treatment of nasopharyngeal carcinoma: state of the art and new perspectives (review). 104
Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters 104
Retinoic acid modulates the radiosensitivity of head-and-neck squamous carcinoma cells grown in collagen gel. 103
Management of Nasal Septum Chondrosarcoma Occurring in Elderly: A Case Report 103
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda 103
Circulating lymphocyte subsets after total lymphoid irradiation in chronicprogressive multiple sclerosis. 102
Chemo-radiation association in head and neck squamous cell carcinoma: Evidences and criticisms 102
Hamming clustering techniques for the identification of prognostic indices in patients with advanced head and neck cancer treated with radiation therapy. 101
Applying radiation protection and safety in radiotherapy 101
Altered fractionation Radiotherapy or radiochemotherapy for patients with HNSCC: impact of meta-analysis results on clinical results. 100
Postoperative radiotherapy for head and neck squamous cell carcinomas: feasibility of a biphasic accelerated treatment schedule. 99
Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant. 99
Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib : an expert panel consensus. 99
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 99
Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis 99
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 99
New chemoradiotherapy combinations in head and neck cancer. 98
The vicious Circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 98
Tissue air ratio in total body irradiation. An in vivo evaluation. 97
Co-culture with human fibroblasts increases the radiosensitivity of MCF-7 mammary carcinoma cells in collagen gels. 97
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 97
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence 97
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. 96
Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: Impact on late toxicity 96
Biological predictors of response to radiotherapy in head and neck cancer: recent advances and emerging perspectives. 95
Lack of a time-factor in alternating chemoradiotherapy for advanced head and neck squamous cell carcinoma. 95
Evaluation of 3-D radiotherapy plans: radiobiological aspects. 94
Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome 94
Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases. 94
Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: Review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. 93
Aspetti Clinici e farmacoeconomici di Loramyc miconazolo in compresse buccali mucoadesive nella candidosi orofaringea del paziente immunodepresso. un'analisi di budget impact per l'Italia 91
A new in vitro model system to study antimycotic drugs. 91
What is the most effective treatment for head and neck squamous cell carcinoma?An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups. 91
Tumor size-driven dose of intraoperative radiotherapy for breast cancer: 18 Gy versus 21 Gy 91
What is the standard in Platinum-based radiochemotherapy in H&N? 90
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 90
Totale 11.004
Categoria #
all - tutte 94.754
article - articoli 68.979
book - libri 652
conference - conferenze 16.831
curatela - curatele 1.593
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.699
Totale 189.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.977 0 0 0 0 589 727 1.448 439 660 1.739 1.052 323
2020/20212.044 115 136 144 119 97 244 111 210 255 246 170 197
2021/20224.698 115 392 141 616 255 405 288 1.060 226 421 131 648
2022/20234.208 489 120 81 353 764 832 15 316 752 12 409 65
2023/20241.868 99 328 47 199 163 306 99 81 117 33 104 292
2024/20251.789 85 602 186 329 587 0 0 0 0 0 0 0
Totale 30.069